Jaqueline França-Costa Selected Research

Diffuse Cutaneous Leishmaniasis

1/2020	Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis.
10/2017	Resolvin D1 drives establishment of Leishmania amazonensis infection.
2/2015	Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis.
1/2012	Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaqueline França-Costa Research Topics

Disease

6	Cutaneous Leishmaniasis 12/2020 - 02/2015
4	Diffuse Cutaneous Leishmaniasis 01/2020 - 01/2012
3	Infections 10/2017 - 01/2012
3	Leishmaniasis 10/2017 - 09/2011
2	Leprosy (Hansen's Disease) 12/2022 - 01/2017
1	Visceral Leishmaniasis (Kala Azar) 01/2017
1	Mucocutaneous Leishmaniasis 04/2016
1	Inflammation (Inflammations) 12/2014

Drug/Important Bio-Agent (IBA)

3	EicosanoidsIBA 10/2017 - 12/2014
2	ArginaseIBA 12/2022 - 02/2015
2	CytokinesIBA 12/2020 - 01/2012
2	PolyaminesIBA 01/2020 - 02/2015
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2017
2	Dinoprostone (PGE2)FDA Link 02/2015 - 12/2014
1	Heme Oxygenase-1IBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	Amino Acids FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 01/2018
1	Meglumine AntimoniateIBA 01/2018
1	resolvin D1IBA 10/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 12/2014
1	Leukotriene B4IBA 12/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2014
1	PhosphatidylserinesIBA 01/2012
1	CaspasesIBA 09/2011
1	Salivary Proteins and PeptidesIBA 09/2011

Therapy/Procedure

2	Therapeutics 01/2018 - 10/2017
1	Chemoprevention 12/2022